炎症性肠病患者慢性背痛中未诊断的中轴型脊柱关节炎患病率:二级医疗横断面研究
该研究向某大学教学医院炎症性肠病门诊连续患者发放筛查问卷,对符合条件且自报慢性背痛超过3个月、起病年龄小于45岁者进行风湿科评估。在91例自报慢性背痛者中,82例符合临床评估条件,未诊断的风湿科确诊中轴型脊柱关节炎估计患病率为5%(95%CI 1.3, 12.0),平均症状持续时间12年(s.d. 12.4)。作者认为炎症性肠病患者中存在显著的隐匿性中轴型脊柱关节炎疾病负担。
要点
- 炎症性肠病门诊自报慢性背痛且起病小于45岁者中,未诊断风湿科确诊中轴型脊柱关节炎估计患病率为5%(95%CI 1.3, 12.0)。
- 该人群平均症状持续时间为12年(s.d. 12.4)。
- 作者认为炎症性肠病患者中存在显著的隐匿性中轴型脊柱关节炎疾病负担。
核心结论
- 炎症性肠病患者中存在显著的隐匿性中轴型脊柱关节炎疾病负担。
- 作者认为需要消化科进行适当的识别和转诊,以可能缩短诊断延迟并使患者获得适当治疗。
研究设计与样本
- 研究为在某大学教学医院炎症性肠病门诊开展的横断面研究,向连续就诊患者发放筛查问卷。
- 纳入标准为消化科医生确诊、年龄18至80岁、未接受生物制剂治疗、既往无中轴型脊柱关节炎诊断,且自报慢性背痛超过3个月、起病年龄小于45岁。
- 符合条件者接受风湿科评估,包括病史回顾、体格检查、患者报告结局指标、人类白细胞抗原B27、C反应蛋白、骨盆X线片及中轴型脊柱关节炎方案磁共振成像检查。
- 中轴型脊柱关节炎诊断由风湿科医生小组作出,为风湿科确诊的中轴型脊柱关节炎。
主要发现
- 在470例被接触的患者中,91例自报慢性背痛超过3个月且起病年龄小于45岁,其中82例符合临床评估条件。
- 在二级医疗炎症性肠病门诊自报慢性背痛、起病年龄小于45岁的患者中,未诊断的风湿科确诊中轴型脊柱关节炎估计患病率为5%(95%CI 1.3, 12.0)。
- 该人群平均症状持续时间为12年(s.d. 12.4)。
临床怎么用
- 作者认为需要消化科进行适当的识别和转诊,以可能缩短诊断延迟并使患者获得适当治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To elucidate the prevalence of undiagnosed rheumatology-verified diagnosis of axial spondyloarthritis (RVD-axSpA) in patients attending routine secondary care IBD clinics with chronic back pain. METHODS: Screening questionnaires were sent to consecutive patients attending IBD clinics in a university teaching hospital. Patients fulling the eligibility criteria (gastroenterologist-verified diagnosis, 18-80 years old, biologic therapy naive, no previous diagnosis of axSpA); and a moderate diagnostic probability of axSpA [self-reported chronic back pain (CBP) >3 months, onset <45 years] were invited for rheumatology assessment. This included medical review, physical examination, patient reported outcome measures, human leucocyte antigen B27, C-reactive protein, pelvic radiograph and axSpA protocol magnetic resonance imaging. A diagnosis of RVD-axSpA was made by a panel of rheumatologists. RESULTS: Of the 470 patients approached, 91 had self-reported CBP >3 months, onset <45 years, of whom 82 were eligible for clinical assessment. The prevalence of undiagnosed RVD-axSpA in patients attending IBD clinics in a secondary care setting, with self-reported CBP, onset <45 years is estimated at 5% (95% CI 1.3, 12.0) with a mean symptom duration of 12 (s.d. 12.4) years. CONCLUSION: There is a significant hidden disease burden of axSpA among IBD patients. Appropriate identification and referral from gastroenterology is needed to potentially shorten the delay to diagnosis and allow access to appropriate therapy.
引用
- Lim CSE, Tremelling M, Hamilton L, et al. Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study. Rheumatology (Oxford). 2023. PMID: 35993905. doi:10.1093/rheumatology/keac473
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。